Lyon

• Chemotherapy for the treatment of standard risk adult medulloblastomas Recruiting
  2024-513243-85-00 4 2023-02-03 Adult medulloblastoma
• TRAK-ER_A randomised trial of early detection of molecular relapse with circulating tumour DNA tracking and treatment with palbociclib plus … Recruiting
  2024-517414-15-00 4 2023-01-25 ER positive HER2 negative breast cancer
• A multicenter phase 1/2 study of OSE-279, a PD-1 blocking monoclonal antibody, in subjects with advanced solid tumors or lymphomas Recruiting
  2024-514826-22-00 7 2022-12-05 Part A: Patients with advanced solid tumors or lymphomas.
• A Phase 1/2 Study of the Selective Anaplastic Lymphoma Kinase (ALK) Inhibitor NVL-655 in Patients with Advanced NSCLC and Other Solid Tumors … Recruiting
  2024-514266-39-00 7 2022-11-03 Advanced Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors wit
• First-in-Human Study of RLY-2608 in Advanced Breast Cancer and Other Solid Tumors. Recruiting
  2022-500264-35-00 1 2022-10-28 Advanced solid tumor with a PIK3CA mutation in blood and/or tumor per
• TERTIO : Evaluation de l’intérêt de combiner un vaccin inducteur de CD4-Th1 dérivé de la télomérase avec un traitement par atezolizumab et b … Recruiting
  2022-500643-20-00 4 2022-09-27 Patients with locally advanced, metastatic or unresectable hepatocellu
• MetroWilms Recruiting
  2022-502687-20-00 4 2022-09-14 Wilms tumor
• Asciminib Roll-over Study Recruiting
  2023-507557-16-00 5 2022-08-31 chronic myelogenous leukemia (CML) or Philadelphia Chromosome positive
• A Phase 1, Open-Label, Multicenter Study of INCB123667 as Monotherapy and in Combination With Anticancer Therapies in Participants With Sele … Recruiting
  2024-512822-28-00 1 2022-08-08 Advanced or metastatic solid tumors
• A Phase 1a/1b Study of ELVN-001 for the Treatment of Chronic Myeloid Leukemia Recruiting
  2023-503335-18-00 1 2022-07-29 Chronic myeloid leukemia
• Study of LY3537982 in Cancer Patients With a Specific Genetic Mutation (KRAS G12C) Recruiting
  2022-502756-31-00 7 2022-07-20 KRAS G12C-Mutant Advanced Solid Tumors
• VAC-WARTS Recruiting
  2024-513671-40-00 5 2022-06-29 HPV vaccine
• RAINBO: Refining Adjuvant treatment IN endometrial cancer Based On molecular features, TransPORTEC platform trials (MMRd-GREEN) Recruiting
  2023-503267-42-00 5 2022-06-10 Patients with a histological diagnosis of mismatch- repair deficient h
• A clinical study to learn about the safety and effects of KIN-2787, a new oral anticancer drug for the treatment of patients with BRAF and/o … Recruiting
  2024-516331-27-00 3 2022-06-10 Participants with BRAF and/or NRAS mutation positive tumors
• Study of axitinib +/- pembrolizumab in first line treatment for patients with locally advanced or metastatic papillary renal cell carcinoma … Recruiting
  2024-513986-38-00 4 2022-06-01 Locally advanced or metastatic papillary cell carcinoma (PRCC)
• Study evaluating the clinical impact of HDM201 + Pazopanib in patients with P53 wild-type advanced/ metastatic soft tissue sarcomas. Recruiting
  2024-510706-86-00 9 2022-05-16 Advanced/ metastatic soft tissue sarcomas
• Brigatinib in pediatric and young adult patients with ALK+ ALCL, IMT or other solid tumors (Briga-PED) Recruiting
  2024-513412-10-00 9 2022-05-11 Anaplastic Large Cell Lymphoma (ALCL)
• A phase II-III randomized trial evaluating maintenance pembrolizumab (± pemetrexed) until progression versus observation (± pemetrexed) afte … Recruiting
  2024-515945-40-00 10 2022-05-02 Non small cell lung cancer
• PEMBROCABOSARC : Combination of pembrolizumab and cabozantinib in patients with advanced sarcomas Recruiting
  2023-509496-16-00 4 2022-04-21 Advanced /metastatic sarcomas: undifferentiated pleomorphic sarcoma, o
• Randomised phase III trial of ADT +/- darolutamide in frail men with castration-naïve de novo metastatic prostate cancer Recruiting
  2022-502425-18-00 5 2022-04-19 Adenocarcinoma of the prostate
• Nivolumab and ipilimumab in patients with dMMR and/or MSI metastatic colorectal cancer resistant to anti-PD1 monotherapy: An open-label phas … Recruiting
  2024-516313-20-00 4 2022-04-19 Metastatic colorectal cancer
• A prospective, randomized, multicenter, comparative study of the efficacy of imatinib resumption combined with atezolizumab versus imatinib … Recruiting
  2022-503068-34-00 4 2022-04-06 Metastatic Gastrointestinal Stromal Tumor
• A Phase 1/2 Study of the Highly Selective ROS1 Inhibitor NVL-520 in Patients with Advanced NSCLC and Other Solid Tumors (ARROS-1) Recruiting
  2024-511793-71-00 7 2022-02-28 Advanced ROS1-positive NSCLC and other advanced ROS1-positive solid tu
• Study evaluating the tailored management of locally-advanced rectal carcinoma Recruiting
  2024-511609-44-00 10 2022-02-03 Rectum cancer

Showing 385–408 of 875 trials